Promising Pharmaceutical Stocks Worth Watching - August 30th
Market Beat·- MarketBeat identified seven pharmaceutical companies with the highest dollar trading volume to watch, including Eli Lilly, Johnson & Johnson, and Pfizer. - These companies offer growth potential through successful drug approvals and strong sales, alongside inherent risks from clinical trials, regulations, and patent expirations. - Investors evaluate these prominent pharmaceutical stocks to balance growth opportunities with industry-specific clinical and regulatory risks.Rakuten Investment Management Inc. Acquires New Position in Pfizer Inc. $PFE
Market Beat·- Rakuten Investment Management Inc. acquired a new position of 931,567 shares in Pfizer Inc. valued at approximately $22,702,000 during the 2nd quarter. - Pfizer reported a quarterly revenue of $15.03 billion and $0.77 earnings per share for the quarter ending in August 2026, beating analysts' consensus estimates. - Institutional investors and hedge funds currently own 68.36% of the company's stock, while the firm announced a quarterly dividend of $0.43 payable on September 1st.40,700 Shares in Pfizer Inc. $PFE Acquired by North Star Asset Management Inc.
Market Beat·- North Star Asset Management Inc. acquired 40,700 shares of Pfizer Inc. valued at approximately $980,000 during the second quarter. - Pfizer reported second-quarter earnings with $0.77 EPS on revenue of $15.03 billion, outperforming analyst estimates. - Institutional investors currently own 68.36% of the company's stock, while various firms adjusted their positions and price targets.